
|Articles|August 15, 2004
Incontinence treatments continue to improve, evolve
As treatment approaches to urinary incontinence continue to evolve, their safety and efficacy relative to existing techniques, and in particular the durability of their results, remain important issues for determining their ultimate place in clinical practice.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
5











